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Abstract
Background: The m-AAA (ATPases Associated with a variety of cellular Activities) is an evolutionary conserved 
metalloprotease complex located in the internal mitochondrial membrane. In the mouse, it is a hetero-oligomer 
variably formed by the Spg7, Afg3l1, and Afg3l2 encoded proteins, or a homo-oligomer formed by either Afg3l1 or 
Afg3l2. In humans, AFG3L2 and SPG7 genes are conserved, whereas AFG3L1 became a pseudogene. Both AFG3L2 and 
SPG7 are involved in a neurodegenerative disease, namely the autosomal dominant spinocerebellar ataxia SCA28 and a 
recessive form of spastic paraplegia, respectively.
Results: Using quantitative RT-PCR, we measured the expression levels of Spg7, Afg3l1, and Afg3l2 in the mouse brain. 
In all regions Afg3l2 is the most abundant transcript, followed by Spg7, and Afg3l1, with a ratio of approximately 5:3:1 in 
whole-brain mRNA. Using in-situ hybridization, we showed that Spg7, Afg3l1 and Afg3l2 have a similar cellular pattern of 
expression, with high levels in mitral cells, Purkinje cells, deep cerebellar nuclei cells, neocortical and hippocampal 
pyramidal neurons, and brainstem motor neurons. However, in some neuronal types, differences in the level of 
expression of these genes were present, suggesting distinct degrees of contribution of their proteins.
Conclusions: Neurons involved in SCA28 and hereditary spastic paraplegia display high levels of expression, but 
similar or even higher expression is also present in other types of neurons, not involved in these diseases, suggesting 
that the selective cell sensitivity should be attributed to other, still unknown, mechanisms.
Background
Mitochondrial AAA-proteases (ATPases Associated with
a variety of cellular Activities) are evolutionary conserved
ATP-dependent metalloproteases that participate in the
assembly of the respiratory chain complexes and ribo-
somes, and in mitochondrial protein quality control [1-3].
In mice, two oligomeric AAA-protease complexes are
present in the mitochondria inner membrane: the i-AAA
protease, formed by the YME1L1 protein, oriented
towards the intermembrane space, and the m-AAA pro-
tease, composed by paraplegin (coded by Spg7), Afg3l1
and Afg3l2, which exposes its catalytic site to the matrix.
It has been recently shown [4] that the m-AAA-protease
formed by paraplegin has a hexameric structure like FtsH,
a better studied bacterial homologue of eukaryotic m-
AAA members [for review see [5]]. In humans, SPG7 and
AFG3L2 only are active genes, whereas AFG3L1 has
become a pseudogene. Both SPG7 and AFG3L2 have
been associated with a human neurodegenerative disease:
SPG7 loss-of-function mutations cause an autosomal
recessive form of hereditary spastic paraplegia (HSP) [6],
in which axons of corticospinal neurons and of soma-
tosensory neurons degenerate [7]; AFG3L2 missense
mutations have been implied in the autosomal dominant
spinocerebellar ataxia SCA28 [8]. A mouse model for
paraplegin deficiency has a motor phenotype that
appears at 4 months, and later shows clear features of
axonal swelling and degeneration of motor descending
and sensory axons [9]. Recently two murine models for
Afg3l2 have been described, one carrying a null mutation,
and a second with a missense mutation in the protease
domain. Afg3l2 defective mice display a marked impair-
ment of axonal development leading to lethality at P16
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Page 2 of 9[10]. Mice homozygous for Spg7 deletion, which in addi-
tion also bear the loss of function Afg3l2Emv66 mutation in
one allele, display a more severe phenotype with an ear-
lier onset of symptoms when compared with Spg7 null
mice, and they also develop a marked cerebellar ataxia
[11,12].
In yeast, Yta12 and Yta10 are the functional ortho-
logues of paraplegin and AFG3L2, since respiratory com-
petence defects induced by deficiency of both Yta12 and
Yta10 are compensated by coexpression of paraplegin and
AFG3L2 [13]. Interestingly, the expression of Afg3l2 is
sufficient to rescue respiratory competence in this model
while paraplegin alone fails to restore m-AAA function,
in line with the finding that Afg3l2 can form homo-oli-
gomers while paraplegin does not [14].
Recently the assembly of paraplegin in m-AAA com-
plexes has been studied in paraplegin deficient HSP fibro-
blasts and in fibroblast from Spg7 -/- mouse model.
Different amounts of paraplegin, Afg3l1, and Afg3l2 pro-
teins were seen in liver and brain, with Afg3l1 being the
less abundant in the latter. The subunit composition of
the proteolytic complex seems therefore to vary in differ-
ent tissues, and possibly within different subregions [14].
It is therefore interesting to evaluate the relative expres-
sion levels of the three murine m-AAA components in
the brain to further correlate their abundance with the
neurodegenerative pathologies associated with SPG7 and
AFG3L2 genes in humans. To this aim, we measured the
relative expression of m-AAA genes by quantitative
reverse-transcriptase polymerase chain reaction (RT-
PCR) in the whole brain and in specific regions (cerebel-
lum, hippocampus, neocortex, olfactory bulb); further-
more, a detailed pattern of expression was studied by in-
situ hybridization under conditions which allowed each
probe a sufficient resolution between neurons with dif-
ferent degrees of expression. The combination of RT-PCR
quantification with in-situ hybridization data allows us to
make a reliable comparison of the expression levels of the
m-AAA transcripts for the first time.
Results
In-situ hybridization analysis of m-AAA protease transcripts 
in the mouse brain
To study the expression of m-AAA genes at a single cell
resolution, we used non-radioactive in-situ hybridization.
The results of this analysis for the most relevant brain
regions are reported in Table 1. It should be noted that
the scoring of expression levels with in-situ hybridization
was relative to the highest intensity of labeling obtained
by each probe, so that the levels can be compared only
within each gene but not between genes. The ratio of
expression levels across the three genes can be derived
taking into account at the same time in-situ hybridization
data together with quantitative RT-PCR results (see the
next section of results).
We noted a wide variability of expression. A virtual
absence of labeling was found in the neurons of the cere-
bellar cortex molecular layer, whereas a very intense
labeling was present in the cerebellar Purkinje cells and in
brainstem motor neurons. In the olfactory bulb, the
expression was intense in the principal cells of the mitral
cell layer, while the glomerular layer showed a moderate
expression and the granule cell layer a barely detectable
signal. Granule neurons of the dentate gyrus and pyrami-
dal neurons of all hippocampal regions showed a moder-
ate to high expression of all transcripts (Fig. 1A). In
contrast to the other two genes, Afg3l2 was also clearly
expressed by hippocampal interneurons, including those
located in the hilus, in stratum oriens, in stratum radia-
tum and in stratum lacunosum-moleculare (Fig. 1A, bot-
tom panel).
All layers displayed a moderate to intense labeling in
neocortex (Fig. 1B), including sparse cells present in the
most superficial layer, more abundant with Afg3l2. The
most salient difference of expression was a more pro-
nounced labeling of layer 5, especially for Afg3l2. The
level of expression was low in the striatum while in the
thalamic nuclei it was moderate.
In the cerebellum (Fig. 2; see also Additional file 1,
panel B, left micrographs), the molecular layer was
devoid of labeling, Purkinje cells were very intensely
stained and in the granule cell layer middle-sized neu-
rons, presumable Golgi cells, displayed a very high
expression, which contrasts with the low labeling of the
small sized granule cells. It is noteworthy that also neu-
rons in the deep cerebellar nuclei were densely labeled,
especially for Spg7 and Afg3l2.
In the brainstem, vestibular nuclei expressed all three
genes at a moderate level. Pontine nuclei, one of the main
sources of mossy fiber afferents to the cerebellum, were
not stained for Spg7, but had a moderate to high expres-
sion of Afg3l1 and Afg3l2. The neuronal type, which dis-
played the highest levels of expression of all three
transcripts in the brainstem, were motor neurons of cra-
nial nerves, including those located in the nuclei inner-
vating oculomotor muscles (III, IV and VI), trigeminal
motor nuclei (V) and facial motor nuclei (VII). Soma-
tosensory cuneate and gracile nuclei also expressed the
three transcripts, at a slightly lower level than brainstem
motor neurons.
Quantitative expression of m-AAA protease transcripts in 
mouse brain regions and in Purkinje cells
The relative expression levels of Spg7, Afg3l1 and Afg3l2
were measured by real-time RT-PCR in the mouse whole
brain and in specific regions manually dissected (see
methods for details). Data were calibrated using the
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Table 1: Expression patterns of m-AAA genes in mouse brain.
Spg7 Afg3l1 Afg3l2
Olfactory bulb
Glomerular layer + ++ +
Mitral cell layer ++ +++ +++
Granular cell layer +/- +/- +/-
Hippocampus
Dentate gyrus ++ ++ +++
Hilus interneurons + + +++
Pyramidal layer ++ ++ +++
Subiculum ++ ++ ++
Stratum radiatum interneurons + +/- +++
Stratum oriens interneurons + +/- +++
Stratum Lac-Mol interneurons + +/- ++
Neocortex
L 1 +/- +/- ++
L 2 ++ ++ ++
L 3 ++ ++ ++
L 4 ++ ++ ++
L 5 ++ ++/+++ +++
L 6 ++ ++ ++
Striatum + + +
Thalamus ++ ++ ++
Cerebellum
Purkinje cells +++ +++ +++
Molecular layer - - -
Granules + ++ +
Golgi cells +++ +++ +++
DCN +++ ++ +++
Brainstem
Vestibular n. ++ ++ ++
Pontine n. - ++ ++/+++
Motoneurons of III, V and VII n. +++ +++ +++
Cuneate n./Gracile n. ++ ++ +
Intensity of labeling of in-situ hybridization: - indicates absence of labeled structures; + mild labeling; ++ moderate labeling; +++ intense 
labeling. The scoring was relative to the highest intensity of each probe, so that the levels can be compared only within each gene but not 
between the three genes analyzed.
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had an expression level, relative to Pgk1, of 0.523 ± 0.021,
Spg7 of 0.311 ± 0.016 and Afg3l1 of 0.109 ± 0.003. In all
analyzed regions, Afg3l2 was always found to be the most
abundant transcript, Afg3l1 the least expressed, whereas
Spg7 displayed an intermediate level of expression (Fig.
3A).
For all transcripts we found the highest levels in the
cerebellum (Fig. 3A). Besides this region, the neocortex
had an expression of Spg7 and Afg3l2 higher that the
average of the whole brain, but showed the smallest
amount of Afg3l1 transcript (Fig. 3A). These results indi-
cate the presence of some regional differences in the
expression of the m-AAA genes. The quantification was
very reproducible across individuals, indicating a stable
area-specific expression of m-AAA protease transcripts.
In the cerebellum the prevalent population of neurons
are granule cells, which express low levels of Afg3l2 and
Spg7. Since it has been recently reported that AFG3L2 is
involved in the SCA28 spinocerebellar ataxia [8], in
which it is likely that Purkinje cells are affected, it is inter-
esting to quantify the relative level of expression of these
cells relative to the average cerebellar expression. In the
whole cerebellum (Fig. 3B), the expression level, relative
to a housekeeping gene (18S rRNA), was 3.13 ± 0.23 for
Afg3l2 and 2.23 ± 0.15 for Spg7. In order to analyze the
level of expression in Purkinje cells extracted from slices
of cerebellar tissue, the cDNA contents of 10 Purkinje
cells were pooled together in order to obtain a constant
and reliable amplification. In Purkinje cells (Fig. 3B) the
expression of both genes was more than fourfold relative
to the cerebellar average, yielding 13.84 ± 2.35 for Afg3l2
and 14.73 ± 2.49 for Spg7, which are significantly higher
than for the whole cerebellum (Student's t-test, P = 0.002
for both). This analysis was not extended to Afg3l1
because the lower levels of expression of this gene pre-
cluded a reliable quantification in Purkinje cells.
Discussion
Mutations in the mitochondrial m-AAA protease genes
cause two different neurodegenerative diseases in
humans: loss of function of SPG7 is associated with an
autosomal recessive form of spastic paraplegia [6],
whereas missense mutations in AFG3L2 have recently
been associated with SCA28 [8].
The expression of the three m-AAA genes (Spg7,
Afg3l1, and Afg3l2), evaluated by in-situ hybridization in
the mouse brain, was nearly ubiquitous; only a few struc-
tures displayed an almost complete lack of expression,
like the molecular layer of the cerebellar cortex. Such a
Figure 1 In-situ hybridization  staining for Spg7, Afg3l1 and Afg3l2 in hippocampus and neocortex. A. Hippocampus. Pyramidal neurons and 
dentate gyrus are labelled with all three antisense probes. Note that interneurons selectively express Afg3l2. Abbreviations: so, stratum oriens; sr, stra-
tum radiatum; slm, stratum lacunosum-moleculare; h, hilus; DG, dentate gyrus; CA1, CA3, hippocampal regions cornu ammonis 1 and 3. B. In-situ hy-
bridization staining for Spg7, Afg3l1 and Afg3l2 in neocortex. Sections of neocortex are shown from the pial surface (top) to the border between layer 
VI and white matter (bottom). With the exception of layer I, which contains only few cells, all layers display a homogeneous distribution of labelled 
cells, with a higher staining of layer V. In the left panel, cortical layers are labelled from I to VI. Calibration bars are 125 μm.
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essential role for the m-AAA complex for neuronal func-
tion. An enriched expression of m-AAA genes was noted
for neurons with large cell bodies, like mitral cells of the
olfactory bulb, hippocampal and neocortical pyramidal
cells, Purkinje and deep nuclei cells in the cerebellum,
and brainstem motor neurons. A similar pattern has been
reported for other mitochondrial proteins, and it might
be related to a higher requirement for mitochondrial
function in large sized neurons [16].
A relative quantification of gene expression between
the three m-AAA genes was performed by real-time RT-
PCR, given that the in-situ hybridization technique only
allows us to compare the expression of each gene in dif-
ferent cell types. In the whole brain, the proportion of
Afg3l1: Spg7: Afg3l2 mRNA was about 1:3:5, as suggested
by previously reported Western blot experiments [14].
The Allen Brain Atlas http://mouse.brain-map.org/ con-
tains information consistent with our results, but with a
faint labeling for Spg7 and without the possibility to
directly compare the levels of expression of the three m-
AAA genes. Our real-time RT-PCR data are in agreement
with a lower expression of Spg7 relative to Afg3l2, but
with a moderate ratio of 3:5, in accordance with our in-
situ hybridization data. Furthermore, the moderate to
high expression of Spg7 in cortical neurons and in
motorneurons is more in line with the neuronal damage
observed in Spg7 null mice [9] and in paraplegin deficient
patients [7]. Our data, combining RT-PCR quantification
with in-situ hybridization, provide the first reliable com-
parison of the expression levels of the m-AAA tran-
scripts, which is not directly possible with either
technique alone.
In our real-time RT-PCR study, Afg3l2 was the most
expressed m-AAA gene in all analyzed brain regions, in
agreement with the result that Afg3l2 can form both het-
ero-complexes with paraplegin or Afg3l1, and homo-oli-
gomers [14]. Overall, the higher abundance of Afg3l2
suggests a more important role for this protein than for
Spg7 and Afg3l1. Indeed, mice lacking functional Afg3l2
display severe motor deficits, leading to paraparesis and
tetraparesis at P12-14, followed by death within P16 [10].
A marked reduction of axonal diameter of cortico-spinal
and peripheral nerve fibers is the most striking alteration
accompanied by signs of axonal damage and demyelina-
tion. The activity of mitochondrial respiratory complex I
and III is reduced, and the cytoplasm of motorneurons,
dorsal root ganglia and cerebellar Purkinje cells contains
clusters of clear vacuoles of possible mitochondrial ori-
gin.
Afg3l1, a pseudogene in humans, is expressed at low
levels in all brain regions analyzed by quantitative RT-
PCR. This low level of expression and the non complete
overlap of expression pattern with the other m-AAA
genes, may explain why in both Spg7 and Afg3l2 knock-
out mouse models Afg3l1 is not able to complement the
lack of any of the two paralogues [9,10]. We also suggest
that the presence of Afg3l1 should not be relevant in
mouse models for SCA28, where a knock-in Afg3l2 is
necessary, due to the fact that all patients reported carry a
missense mutation [[8]; Cagnoli et al., in preparation].
Spg7 and Afg3l2 are expressed in the cell types related
to HSP and SCA28, respectively: Spg7 is highly expressed
in neocortical pyramidal cells and in motor neurons, and
Afg3l2 is highly expressed in cerebellar Purkinje cells.
Despite the fact that, in Purkinje cells, Spg7 is expressed
at similar levels as Afg3l2, in SCA28 the function of
mutated AFG3L2 cannot be substituted by paraplegin, in
line with the inability of paraplegin to form homo-oli-
gomers [14]. The high expression of Afg3l2 in brainstem
motor neurons may also relate to the ophthalmoparesis,
Figure 2 In-situ hybridization staining for Spg7, Afg3l1 and Afg3l2 
in cerebellum. Panels on the left show overviews of cerebella cut 
along sagittal planes. Panels on the right show the central portion of 
cerebella at a higher magnification. Note the intense staining of 
Purkinje cells and of neurons of deep cerebellar nuclei. The molecular 
layer is devoid of labeling. Abbreviations: ml, molecular layer; gl, gran-
ular layer; pcl and arrow, Purkinje cell layer. Calibration bars are 250 μm 
for left column and 125 μm for right column panels.
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ever, we found that m-AAA genes are also expressed at
high levels in cell types not directly involved in the corre-
sponding human pathology, suggesting pathogenetic
mechanisms not simply based on reduced function but
on more subtle alterations.
Conclusions
In the mouse brain, Afg3l1: Spg7: Afg3l2 are expressed at
relative levels of 1:3:5. The expression is high in neurons,
which are affected in neurodegenerative pathologies
associated with SPG7 and AFG3L2 genes in humans.
However, taken together, our results indicate that the
neurons affected in HSP and SCA28 do not express selec-
tively Spg7 or Afg3l2 respectively, nor show the highest
brain levels of their relevant transcripts. This suggests
that the reason of the cell-specific effect of Spg7 or Afg3l2
mutations cannot be attributed to selective or particularly
high expression levels in a given cell type, but to other
still unknown mechanisms.
Methods
In-situ hybridization of mouse brain
Non radioactive in-situ hybridization was performed on
brains collected from adult mice of the the outbred CD-1
line, of 6 months of age (Harlan, Corezzana, Italy). The
mice were anaesthetized with isoflurane (Isoflurane-vet,
Merial, Milan, Italy) and decapitated. Animal procedures
were approved by the Animal Care and Use Committee of
the University of Turin. Upon sacrifice, their brains were
embedded in OCT (VWR International LTD, Poole, Eng-
land) and immediately frozen in -80°C 2-methylbutane.
Sections (15 μm) were cut by a cryostat (Leica Microsys-
tems GmbH, Wetzlar, Germany) and mounted on Super-
Frost Plus glass slides (Menzel GmbH&Co KG,
Braunschweig, Germany). All steps were performed at
room temperature, unless otherwise specified. Sections
were fixed in 4% paraformaldehyde (Merck KGaA; Darm-
stadt, Germany) in PBS for 10 minutes, and then permea-
bilized with 0.5% Triton X-100 (Merck KGaA; Darmstadt,
Germany) in PBS. An acetylation step was performed
using a solution containing triethanolamine and acetic
anhydride (both from Merck KGaA; Darmstadt, Ger-
many). After washing with PBS, a pre-hybridization reac-
tion was performed in a solution containing 50%
formamide (Euroclone Ltd., Pero, Italy), 2% Blocking
Reagent (Roche Diagnostic Corporation, Indianapolis,
IN, USA) and 5× SSC. Before the hybridization step,
probes were incubated at 85°C for 5 minutes and then on
ice, in order to be sure that they were unfolded. We used a
set of digoxigenin-labeled riboprobes that span the tran-
scripts of Spg7, Afg3l1 and Afg3l2 genes; each riboprobe
was transcribed in the presence of T3 or T7 RNA poly-
merase from the appropriately restricted Bluescript plas-
mid containing the gene fragment of interest (see
Additional File 2 probe sequence).
To verify that the probes used in our in-situ experi-
ments were specific, we performed a slot blot assay. We
prepared three filters each containing three plasmid
clones with the full length cDNA of Spg7, Afg3l1 and
Afg3l2 murine genes (IRCKp5014I0315Q, IRAKp961
C11116Q, and IRAVp968B08129D6, Imagenes). After
denaturation with NaOH 0.5 M, EDTA 10 mM, we spot-
ted one-hundred nanograms of each clone onto a N+
nylon filter (Amersham-Pharmacia) using a slot blot
apparatus (Biorad). The DNA was covalently bound to
Figure 3 Levels of expression of Spg7, Afg3l1 and Afg3l2. A. Real time RT-PCR measures, calibrated relative to the housekeeping gene Pgk1. Bars 
represent standard errors. B. Real-time RT-PCR analysis of Afg3l2 and Spg7 transcripts in the whole cerebellum and in pools of Purkinje cells. The ex-
pression levels are relative to the 18S rRNA.
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hybridised using the Quick-Hyb hybridisation solution
(Roche Diagnostics) in the condition specified. Probes
were obtained from PCR amplification and gel-purifica-
tion using QIAquick gel extraction kit (Qiagen), and cor-
responded in sequence to the probes used for in-situ
experiments. The probes were radiolabelled with 32-P-
dCTP using High Prime labelling kit (Roche Diagnostics).
The filters were exposed for 15 min at room temperature.
The results [Additional file 1, panel A] show that all
probes are specific and only recognize the full length
cDNA of the corresponding gene. A very faint cross-
hybridisation with Spg7 is present for the Afg3l1 probe.
Each riboprobe was transcribed as antisense, which
specifically labeled the target mRNA as expected, and as
sense, to control for unspecific binding or for background
staining due to the endogenous alkaline phosphatase
activity of the tissue. Examples of sense and antisense
labeling are illustrated in panel B of the supplementary
fig. [Additional file 1, panel B].
Twenty nanograms of each probe were added to the
slices and the hybridization was carried out at 65°C over-
night. Washing steps included incubations in 5× SSC and
in 0.2× SSC at 65°C for one hour, followed by 5 minutes in
0.2× SSC and 5 minutes in MABS at room temperature.
Sections were incubated in 1% Blocking Reagent (Roche
Diagnostic Corporation, Indianapolis, IN, USA) in MABS
buffer for one hour and then in an AP-coniugated anti-
digoxigenin Fab fragment (1:5000 dilution, Roche Diag-
nostic Corporation, Indianapolis, IN, USA) for one hour.
After two washing steps of 30 minutes in MABS buffer
and 5 minutes in Buffer 3, the reaction was developed
overnight with BCIP/NBT substrate (Sigma-Aldrich, St.
Louis, MO, USA). When the color reaction was com-
pleted, sections were washed in Buffer 4 and in PBS for
some minutes. The slides were examined by means of a
Zeiss Axiophot light microscope (Zeiss, Oberkochen,
Germany). Micrographs were taken by means of a Nikon
Coolpix 950 digital camera (Nikon, Mellville, NY, USA)
attached to the same microscope. Images were processed
using Adobe Photoshop CS2 9.0.2 (Adobe System, San
Josè, CA, USA).
Real Time RT-PCR analysis of the mouse brain
The quantitative RT-PCR analysis of the transcripts was
performed on hemibrains and on dissected brain regions
collected from 5 female CD-1 mice (Harlan, Corezzana,
Italy) at 6 months of age. The mice were anaesthetized
with isoflurane (Isoflurane-vet, Merial, Milan, Italy) and
decapitated. Animal procedures were approved by the
Animal Care and Use Committee of the University of
Torino. The brains were quickly removed from the skull,
placed in an ice-cold artificial liquor (containing, in mM:
125 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2, 1.25 NaH2PO4, 26
NaHCO3, 20 glucose, bubbled with 95% O2- 5% CO2). For
the analysis performed on the dissected brain regions, the
cerebellum and olfactory bulbs were manually dissected
immediately after the whole brain collection. Then, coro-
nal sections from neocortex and hippocampus were cut
using a vibratome (Leica Microsystems GmbH, Wetzlar,
Germany), starting from Bregma 1.10 mm. First, two 400
μm thick slices were cut in order to collect samples of
neocortex. The two hippocampal slices (400 μm thick)
were cut starting from Bregma -1.50. White matter parts
were manually separated and not included in the gene
expression analysis. Stereotaxic coordinates were
obtained from the mouse brain atlas "The mouse brain in
stereotaxic coordinates" [18]. All samples were rapidly
frozen and stored at -80°C.
Total RNA was isolated by extraction with the commer-
cially available TRIzol Reagent (Invitrogen Life Technolo-
gies Inc., Grand Island, NY, USA), in accordance with the
manufacturer's instructions. Genomic DNA was elimi-
nated by treating the extracted RNA with DNase
(Deoxiribonuclease I; Sigma-Aldrich). RNA concentra-
tion and purity were evaluated prior and after the DNase
treatment by spectrophotometry. The absence of RNA
degradation was confirmed by agarose gel electrophore-
sis. RNA samples were stored at -80°C.
One μg of total RNA was reverse-transcribed to cDNA
using the commercial High-Capacity cDNA Archive Kit
(Applied Biosystems, Foster City, CA, USA), according to
the manufacturer's instructions. Negative controls of the
reverse transcription were always performed. cDNA sam-
ples were stored at -20°C.
Quantitative Real Time PCR was carried out using the
ABI Prism 7000 Sequence Detection System instrumen-
tation (Applied Biosystems). Taqman Gene Expression
Assays were purchased from Applied Biosystems to
determine the amount of the three target genes (Afg3l2
cod. Mm01258204_m1, Afg3l1 cod. Mm00475312_m1,
Spg7 cod. Mm00462651_m1) and the housekeeping gene
phosphoglycerate kinase 1 (Pgk1, cod. Mm004356
17_m1). PCR amplifications were performed on cDNA
samples corresponding to a final RNA concentration 200
pg. PCR was performed according to the following reac-
tion conditions: 50°C for 2 minutes, 95°C for 10 minutes,
followed by 50 cycles 95°C for 15 seconds alternating with
60°C for 1 minute. Blank controls were performed on
each plate.
For the quantitative comparison of the genes, data
extracted from each real time RT-PCR run were analysed
by means of the 7000 v1.1 SDS instrument software
(Applied Biosystems). The CT (Cycle Threshold) was
automatically calculated and used to quantify the starting
copy number of the target mRNA. The amounts of the
target RNA copies were normalized to the endogenous
reference Pgk1, because it shows a low variation among
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tone et al. [19] to compensate for small differences in the
efficiency of amplification among target and housekeep-
ing genes.
For a comparison of the level of expression of Afg3l2
and Spg7 transcripts in the cerebellum relative to
Purkinje cells, the analysis was performed on 8 cerebella
and 5 pools (10 cells each) of Purkinje cell (PCs), collected
from another set of 11 adult female CD-1 mice (Harlan,
Corezzana, Italy) at 6 months of age. The cerebellum was
quickly removed under semi-sterile conditions and either
rapidly frozen in -80°C 2-methylbutane and stored at -
80°C (8 cerebella) or, for slice preparation, placed in the
artificial liquor described above, bubbled with 95% O2-
5% CO2. To collect PCs, parasagittal sections (200 μm
thickness) of the vermis of 3 cerebella were prepared
using a vibratome. Single PCs were aspirated into
micropipettes under visual control; the tips of the
micropipettes were broken into empty 0.2 ml Eppendorf
tubes. The entire RNA of each cell was retrotranscribed
using the High-Capacity cDNA Archive Kit (Applied Bio-
systems). The cDNA was purified and concentrated using
the QIAEX II Gel Extraction Kit (Qiagen, Hilden, Ger-
many). Quantitative PCR and data analysis were per-
formed as described above. For the comparison of the
Afg3l2 and Spg7 transcripts in the cerebellum relative to
Purkinje cells, each sample was normalized to the level of
the 18S rRNA (Applied Biosystems, cod.4319413E).
Transcript expression differences were statistically evalu-
ated by means of a one way ANOVA test or Student's t-
test. A P value < 0.05 was considered significant. All
results were expressed as mean ± standard error (SE).
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